Press Releases
21 October 2019
SAN DIEGO, Oct. 21, 2019 /PRNewswire/ -- Histogen, Inc., a regenerative medicine company with a unique biological platform that replaces and regenerates tissues in the body, announced today that it will be featured as a presenting company at the 2019 BIO Investor Forum. The event is being held October 22-23, 2019 at The Westin St. Franc
Read more...21 October 2019
LOS ANGELES, Oct. 21, 2019 /PRNewswire/ -- While the eyes may be the window to the soul, if one thing is for certain, eyelashes are certainly the gatekeepers. Individuals who have recently received an eyelash extension and still deal with loss of lashes or those who simply wish to obtain natural, longer-looking eyelashes but never could because of genetic limi
Read more...21 October 2019
ATLANTA, Oct. 21, 2019 /PRNewswire/ -- The FH Foundation, a leading research and advocacy organization, announced today that a machine learning algorithm effectively identified
Read more...21 October 2019
DALLAS, Oct. 21, 2019 /PRNewswire/ -- GI Alliance, the nation's leading physician-led GI services organization, announced today that it has partnered with 17 physicians in San Antonio from the practices of San Antonio Gastroenterology Associates (SAGA) and San Antonio Digestive Disease Consultants (SADDC). The founders of SAGA built the f
Read more...RIDGELAND, Miss., Oct. 21, 2019 /PRNewswire/ --
Read more...21 October 2019
ABBOTT PARK, Ill., Oct. 21, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the Australian Red Cross Blood Service (Australian Blood Service) has signed a multiple-year agreement for Abbott's most advanced blood and plasma screening technology, Alinity™ s System. The Australian Blood Service collects 1.5 million donations each year, providing a safe blood supply to 25 million Aus
Read more...NEW ORLEANS, Oct. 21, 2019 /PRNewswire/ -- Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, today announces new data evaluating initial combination therapy with OPSUMIT® (macitentan) and tadalafIl, a PDE5 inhibitor. Patients with pulmonary arterial hypertension (PAH, WHO Group 1) taking this combination showed hemody
Read more...SAN FRANCISCO, Oct. 21, 2019 /PRNewswire/ -- 7D Surgical announced today at the Congress of Neurological Surgeons Annual Meeting that it has completed 30 sales since commercial launch of its innovative Machine-vision Image Guided Surgery (MvIGS) platform for spinal and cranial surgery. This achievement represents installations throughout
Read more...LEVERKUSEN, Germany and ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- CRISPR Therapeutics and Bayer today announced proposed plans whereby Casebia Therapeutics, a joint venture between CRISPR Therapeutics and Bayer, would operate under the direct management of CRISPR Therapeutic
Read more...21 October 2019
LINDON, Utah, Oct. 21, 2019 /PRNewswire/ -- TheraLight, LLC, a Utah private corporation, announced that it was selected by MedTech Outlook as a recipient of its 2019 Top 10 Physiotherapy Solutions Providers Award. Conducted annually, the award recognizes innovative companies in the healthcare industry. TheraLight is providing new opt
Read more...